Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548756 · ClinicalTrials.gov registry record · Phase 3
Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy
A Phase 3 study of Brain Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT00548756 is a Phase 3 study of Brain Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 152 participants, below the 504-participant average among 47 other Brain Cancer trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00548756, a Phase 3 study of Brain Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn if your thinking ability (cognitive function) will be better preserved by delivering whole brain radiation therapy immediately after radiosurgical treatment of 1-3 brain metastases or to carefully observe patients after radiosurgery and hold back whole brain radiation therapy until the disease comes back.
Conditions Studied
Interventions
- OTHER Observation
- BEHAVIORAL Questionnaire
- PROCEDURE Whole Brain Radiation Therapy
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2001-01-02 |
| Est. Completion | 2023-06-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00548756
The ClinicalTrials.gov registry entry for NCT00548756 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 504-participant average among 47 other Brain Cancer trials with a reported enrollment target (70% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain Cancer appearing as the primary indexed condition, and to 3 interventions - of which Observation is the first listed.
NCT00548756 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00548756 about?
NCT00548756 is a clinical study titled "Randomized Trial Comparing Radiosurgery With vs Without Whole Brain Radiotherapy". The goal of this clinical research study is to learn if your thinking ability (cognitive function) will be better preserved by delivering whole brain radiation therapy immediately after radiosurgical treatment of 1-3 brain metastases or to carefully observe patients after radiosurgery and hold back ...
What is the current status of trial NCT00548756?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 152 participants. The study started on 2001-01-02. Estimated completion is 2023-06-02.
What conditions does trial NCT00548756 study?
This clinical trial studies the following conditions: Brain Cancer.
What interventions are being tested in trial NCT00548756?
The interventions under investigation include: Observation (OTHER), Questionnaire (BEHAVIORAL), Whole Brain Radiation Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00548756?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00548756 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
RECRUITING · Phase 3
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
RECRUITING · Phase 1
-
Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
RECRUITING · Phase 1
-
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.